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BLOOD VESSELS OF THE INTRATUMORAL SEPTA 
IN UTERINE LEIOMYOMATA
Abstract: The angioarchitecture of fibroid intratumoral septa was studied using 32 uteri obtained 
during necropsies of the females aged between 35–57. The whole vascular bed of 16 uteri was in-
jected with synthetic resin Mercox CL-2R and then the uteri were corroded in potassium hydroxide. 
Next 16 uteri were injected with acrylic emulsion, Liquitex R. Their vascular bed was studied using 
immunohistochemistry for von Willebrandt’s factor.
Immunohistochemistry allowed to visualize the vessels within the intratumoral septa, while SEM 
allowed to differentiate the vessels, which were mainly the venules and the veins. Apart from the 
veins the intratumoral septa were consisted of small arteries and capillaries.
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INTRODUCTION
Uterine leiomyomata are usually multiple tumours of the female internal genital 
organs which seem to be the clones of the single smooth muscular cells [1]. They 
use to develop their own, specific vasculature [2, 3]. The whole process of growth 
of new vessels within uterine leiomyomata is controlled by many factors, altho-
ugh it may also happen that tumor up- or downregulates creation of angiogenic 
factors, causing dysbalance in activity of factors which are pro- or antiangiogenic 
[4–12]. Females with fibroids may present with irreducible chronic pelvic pain, 
menorrhagia, dysmenorrhea, infertility, recurrent miscarriage, preterm delivery 
or preterm rupture of the placental membranes. Different studies showed that 
peripheral region of fibroid, the so called capsule or pseudocapsule or vascular 
capsule is a place of significantly increased activity of different members of family 
of vascular growth factor [13–17]. Walocha et al. [2, 18] distinguished two types 
of vascularization of intramural uterine fibroid: a type where peripheral vessels 
form relatively dense vascular capsule, while the center of the lesion seems to 
be poorly vascularized and type two, where foci of intensive regression of tumor 
are separated by strong vascular septa. In this last location multiple tumours are 
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characterized by the presence of reach vascular, connective tissue intratumoral 
septa. Their vascular structure was the main interest of this study.
MATERIAL AND METHODS
Studies were carried out on 32 human uteri obtained during necropsy of wo-
men aged 25–56 years, deceased due to causes not related to disorders of the 
reproductive system. The material was collected 6–24 h after death. Each uterus 
together with ovaries and cervical portion of the vagina was removed in such 
a way that relatively long fragments of uterine and ovarian vessels (arteries and 
veins) were retained.
Immediately after removal, sixteen uteri were perfused via the afferent arteries 
with prewarmed (37oC), heparinized saline (12.5 IU/ml heparin; Polfa, Poland, 
containing 3% dextrane (70kDa) and 0.025% lidocaine (Lignocaine; Polfa, Poland), 
until the fluid outflowing via the veins was completely transparent (~5 min). Next 
perfusion was continued using a solution of 0.66% paraformaldehyde/0.08% glu-
taraldehyde (Sigma, Germany) in 0.1 mol/l cacodylate buffer, pH 7.4 supplemen-
ted with 0.2% lidocaine. Finally, the vascular system was injected with 60–80 ml 
of Mercox CL-2R resin (Vilene Comp. Ltd. Japan) containing 0.0625 mg/ml me-
thyl acrylate polymerization initiator (Vilene Comp. Ltd., Japan) and the uteri 
were left in a warm water bath (56oC) for several hours to allow polymerization 
and tempering of the resin.
When the polymerization was completed, the uterine tissues were macerated 
for 5–6 days by repeated baths in 10% potassium hydroxide at 37oC followed by 
washing with warm (50–55oC) running tap water. The obtained vascular casts 
were washed for the next 4–5 days in multiple changes of distilled water under 
mild vacuum conditions, cleaned in 5% trichloroacetic acid for 1–2 days, washed 
again in distilled water for 2–3 days and freeze-dried in a lyophilizer (Liovag G2; 
Aqua Fina, Germany). Next the casts were embedded in a mixture of poliethy-
lenoglycols [19].
The casts were gently dissected to expose the vasculature of myomata and 
stored in an exiccator containing phosphorus pentoxide until the microscopic 
examination. They were then mounted onto copper plates using colloidal silver 
and ‘conductive bridges’ and coated with gold. The casts were examined using 
a JEOL SEM 35-CF scanning electron microscope at 20–25 kV.
The vascular beds of next sixteen uteri were perfused with saline and next 
injected with the solution of acrylic emulsion (Liquitex R, Binney and Smith, USA) 
[20]. The specimens were collected mainly from large fibroids >3 cm in diameter. 
All tissue specimens were fixed in 10% formalin and embedded in paraffin wax. 
Tissue blocks were sectioned (4 μm) and section mounted on aminopropyltriethoxy-
silane (APES)-coated slides. The endothelial cell marker was factor VIII-related 
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antigen (FVIII). Next tissue blocks were deparaffinised, hydrogen peroxidase (3%) 
in methanol was applied to tissue sections as an endogenous peroxidase block 
for 10 min. Protein blocking steps included the application of 10% normal rabbit 
serum prior to the application of the primary antibody (anti Human von Wille-
brandt factor, Dako, USA) in 20% fetal calf serum. After incubation with primary 
antibody, a biotynyled secondary antibody was applied followed by horseradish 
peroxidase-streptavidin conjugate, and visualization with the chromogen 3-amino 
9-ethylchlorcarbazole (AEC, Zymed, USA) which identifies tissue antigens with 
a red-brown stain. Serial sections were immunostained using the endothelial cell 
marker. Negative controls used substitution of the primary antibody with the 
non-immune serum for the polyclonal factor VIII antibody. 
RESULTS
High frequency rate of uterine leiomomata cause these tumours to be the most 
common benign neoplasms of female internal genital tracts. Fibroids can develop 
in different location: we can distinguish fibroids of the corpus and the cervix; 
they can grow subendometrially, intramurally and in the subserous location. 
In each location however multiple tumours are characterized by the presence 
of intratumoral septa. The smallest leiomyomata observed in SEM were usually 
avascular — potentially strong center of hypoxia localized in the middle of the 
lesion is able to stimulate angiogenic factors which produce the vascular capsule 
in the periphery of the tumor. Middle sized tumors are characterized by well-de-
veloped vascular capsule and could be occasionally traversed by small vessels 
(arteries and veins) [21, 22]. Large, bigger than 1 cm leiomyomata contain rather 
poorly organized network of blood vessels. Farrer-Brown suggested that direction 
of blood vessels follows chaotic course of smooth muscle fibers [23–25].
Typical HE study of slides showed the presence of large vessels (both arteries 
and veins) within the intratumoral septa (Fig. 1, Fig. 2). Immunohistochemical 
reaction for von Willebrand factor showed small not injected vessels (Fig. 3). 
SEM allowed us to perform qualitative evaluation of the blood vessels, which 
were mainly the venules and the veins (Fig. 4). As one can see in the figure the 
veins were mainly compressed, probably by growing tumor masses and resembled 
finger-like flattening. Apart from the veins the intratumoral septa were consisting 
of the few small arteries and more numerous capillaries.
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Fig. 1. Uterus of 39 year old female. Corrosion cast. SEM. Veins, small arterioles and capillaries  
of the tissue septa within a large fibroid (F). Artery — A; V — vein; V* — venule; C — capillary. 
Bar = 1000 μm.
Fig. 2. Uterus of 46 year old female. Arteries injected with acrylic emulsion Liquitex R  
(Binney and Smith, USA). HE. Magn. 20 ×.
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Fig. 3. Uterus of  47 year old female. Veins injected with acrylic emulsion Liquitex R  
(Binney and Smith, USA). HE. O — outer fibroid region. S — septa; * — injected veins;  
→ — non-injected capillaries. Magn. 20 ×.
Fig. 4. Uterus of 46 year old female. Veins (*) injected with acrylic emulsion Liquitex R (Binney and 
Smith, USA). O — outer fibroid region; S — intraleiomomatous septa. Numerous empt small venules 
and capillaries (arrows). Immunohistochemical reaction for von Willebrand reaction. Magn. 20 x.
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DISCUSSION
Several authors, specially these classical [26–29], postulated decreased density 
of blood vessels in the tumor. It was especially well visible at the border regions 
between normal and fibroid tissue, where in SEM we could observe avascular gap. 
It was the most probably resulted from accumulation of connective tissue in the 
fibroid pseudocapsule [2, 3], which was corroded during specimen maceration. 
Initial development of small leiomyomatous foci is associated with regression 
of blood vessels of the host organism. Intramural leiomyomata, specially these 
of greater size, revealed the presence of connective tissue septa, which separated 
the foci of increased proliferation. These septa were penetrated by numerous ves-
sels which could be identified in SEM or seen in histological specimens Vessels 
of septa were consisted mainly of digitate flattened veins and capillaries [2, 3, 
18, 30]. Only few arteries were visible. It cannot be excluded that density of the 
blood vessels within the myometrium and uterine fibroids is similar, because most 
of the leiomyoma is composed of extracellular matrix. Corrosion casting tech-
nique aided by SEM is still a method which allows to observe quasi 3D picture 
of leiomyoma vasculature — it can be certainly used to evaluate normal and 
other pathological tissues [31–33]. It is especially interesting tool when it comes 
to see the “vascular capsule” or intramural septa, however as we proved in our 
study, SEM lets to see the vascular nature of the inner regions of the lesion. Most 
of the recent techniques concentrating on treatment of uterine leiomyomas pro-
pose mechanical or hormonal intervention [2, 34–38]. Two most common non-
surgical treatments, GnRHa therapy and uterine artery embolization, act both 
to decrease or even bloc blood flow to the fibroid. In our opinion further investi-
gation on the fibroid treatment regarded to penetration of the medium into the 
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